Download Fortebet App FDA approves world's first intravenous drug for migraine prevention Detained for 10 days and fined 500 yuan! The latest prog ...

Giovanili beach volley Breaking news! Chinese scientists reveal the mechanism of CAR-T cells triggering cytokine release syndrome Can Pfizer's co ...

Merkur stavebnice New drug for major depression! GSK Bupropion Hydrochloride Sustained-Release Tablets (I) approved in China Breaking news! Chinese sc ...

The usual reason for such sudden fatalities is given as massive cardiac arrests or fatal brain strokes. However, everybody ...

Chugai Pharma receives Japanese regulatory approval for Lunsumio for intravenous infusion for relapsed/refractory follicular lymphoma: Tokyo Saturday, December 28, 2024, 13:00 Hrs ...

INR:3433. play free casino slot machine Breaking news! Chinese scientists reveal the mechanism of CAR-T cells triggering cytokine release syndrome B ...

At the recent American Society of Hematology annual meeting, early data from the Mithic-FL1 Trial demonstrated impressive ...

PRINCETON, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO) announces the commencement of its Rights Offering, previously detailed in our December 9, 2024 announcement ...

During a Case-Based Roundtable® event, Hira Shaikh, MD, and participants discussed how they would treat a patient with ...

Get Cytokine storm syndrome News on Telangana Today, Cytokine storm syndrome latest news, Cytokine storm syndrome news, | Telangana Today ...

Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses ...

Bicistronic CAR T-cell therapy can produce durable complete responses in pediatric patients with relapsed or refractory B-ALL, data suggest.